Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies
Raffaella Vergura(University of Ferrara), Girolamo Calò(University of Padua), David G. Lambert(Griffith University), Gianfranco Balboni(University of Cagliari), Christopher Hebbes, Elaine C. Gavioli(University of Ferrara), D. Regoli(University of Ferrara), Severo Salvadori(University of Ferrara), Barbara Spagnolo(University of Salento), John McDonald, E. Valenti(University of Ferrara)
Cited by 18
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization
|Trends in Pharmacological Sciences|1988|358